Skip to main
DHR

Danaher (DHR) Stock Forecast & Price Target

Danaher (DHR) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 47%
Buy 35%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Danaher is a well-established and diversified company with a strong focus on innovation and sustainability. Their commitment to sustainability, coupled with their position in the growing life sciences and biotech industries, gives them a competitive edge and potential for long-term growth. However, in the event of slower growth, the company's stock value may be affected by concerns over the premium pricing of their tools division.

Bears say

Danaher is a well-known industrial manufacturing company that primarily focuses on manufacturing scientific instruments and consumables for the life sciences and diagnostic industries. While the company has a strong history of growth through mergers, acquisitions, and divestitures, there are key risks to their future performance, including the potential for a slow or non-existent recovery in bioprocess equipment demand and continued difficulties in the Chinese diagnostic market. Additionally, while the company has a culture of continuous improvement, there are concerns about their recent acquisitions not meeting expectations and the potential impact of AI on their businesses.

Danaher (DHR) has been analyzed by 17 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 35% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Danaher and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Danaher (DHR) Forecast

Analysts have given Danaher (DHR) a Buy based on their latest research and market trends.

According to 17 analysts, Danaher (DHR) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $230.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $230.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Danaher (DHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.